Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Gynecology and Breast Care Center, Mater Olbia Hospital, Olbia, Italy.
Ultrasound Obstet Gynecol. 2021 Nov;58(5):766-772. doi: 10.1002/uog.23613. Epub 2021 Oct 6.
To evaluate the feasibility and clinical application of fusion imaging with virtual navigation, combining F-fluorodeoxyglucose ( F-FDG) positron emission tomography/computed tomography (PET/CT) with real-time ultrasound imaging, in assessing superficial lymph nodes in breast-cancer and gynecological-cancer patients.
This was a pilot study of breast- and gynecological-cancer patients with abnormal uptake of F-FDG by axillary or groin lymph nodes on PET/CT scan, examined at our institution between January 2017 and May 2019. Fusion imaging was performed, uploading preacquired PET/CT DICOM images onto the ultrasound machine and synchronizing them with real-time ultrasound scanning performed at the lymph-node site. In the first phase, we assessed the feasibility and reliability of fusion imaging in a series of 10 patients with suspicious lymph nodes on both PET/CT and ultrasound, and with full correspondence between both techniques in terms of size, shape and morphology of the lymph nodes (Group A). In the second phase, we included 20 patients with non-corresponding findings between PET/CT and ultrasound: 10 patients with lymph nodes that were suspicious or pathological on PET/CT scan but not suspicious on ultrasound assessment (Group B), and 10 patients with suspicious or pathological lymph nodes on both PET/CT and ultrasound but with no correspondence between the two techniques in terms of number of affected lymph nodes (Group C).
In the 30 selected patients, fusion imaging was assessed at 30 lymph-node sites (22 inguinal and eight axillary nodes). In the first phase (Group A), the fusion technique was shown to be feasible in all 10 lymph-node sites evaluated. In the second phase, fusion imaging was completed successfully in nine of 10 cases in Group B and in all 10 cases in Group C. In all groups, fusion imaging was able to identify the target lymph node, guiding the examiner to perform a core-needle aspiration biopsy or to inject radiotracer for selective surgical nodal excision, according to the radio-guided occult lesion localization technique.
Fusion imaging with virtual navigation, combining PET/CT and real-time ultrasound imaging, is technically feasible and able to detect target lymph nodes even when PET/CT and ultrasound findings are inconsistent. Fusion imaging can also be used to guide the performance of core-needle aspiration biopsy, avoiding further surgical diagnostic procedures, or the injection of radiotracer for selective surgical nodal excision, enabling more sparing, selective surgery. This innovative technique could open up multiple diagnostic and therapeutic opportunities in breast and gynecological oncology. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
评估融合成像技术结合 F-氟脱氧葡萄糖(F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)与实时超声成像在评估乳腺癌和妇科癌症患者浅表淋巴结中的可行性和临床应用。
本研究为在我院 2017 年 1 月至 2019 年 5 月期间进行的腋窝或腹股沟淋巴结 F-FDG 摄取异常的乳腺癌和妇科癌症患者的初步研究。将 PET/CT 采集的 DICOM 图像上传至超声机器,并与在淋巴结部位实时超声扫描同步,进行融合成像。在第一阶段,我们评估了融合成像在 10 例 PET/CT 和超声均怀疑有淋巴结且淋巴结大小、形状和形态完全一致的患者中的可行性和可靠性(A 组)。在第二阶段,我们纳入了 20 例 PET/CT 和超声检查结果不一致的患者:10 例 PET/CT 扫描发现可疑或病理性淋巴结而超声评估无异常(B 组),10 例 PET/CT 和超声均发现可疑或病理性淋巴结但两种技术发现的受累淋巴结数不一致(C 组)。
在 30 例选定患者中,对 30 个淋巴结部位(22 个腹股沟和 8 个腋窝淋巴结)进行了融合成像评估。在第一阶段(A 组),10 个淋巴结部位的融合技术均可行。在第二阶段,B 组的 10 例和 C 组的 10 例均成功完成了融合成像。在所有组中,融合成像均能识别目标淋巴结,根据放射性引导隐匿性病变定位技术指导检查者进行核心针抽吸活检或注射放射性示踪剂以选择性进行外科淋巴结切除。
结合 PET/CT 和实时超声成像的虚拟导航融合成像在技术上是可行的,即使 PET/CT 和超声检查结果不一致,也能检测到目标淋巴结。融合成像还可用于引导核心针抽吸活检,避免进一步的手术诊断程序,或注射放射性示踪剂以选择性进行外科淋巴结切除,从而实现更节约、更有选择性的手术。这项创新技术可能为乳腺和妇科肿瘤学带来多种诊断和治疗机会。© 2021 年国际妇产科超声学会。